Ambroxol Hydrochloride for Injection
Function and Efficacy
This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity; it can also promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up.
Ingredients
The main ingredient of this product is ambroxol hydrochloride.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| Ambroxol hydrochlorideIngredients |
This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity; it can also promote the secretion of pulmonary surfactant, increase bronchial ciliary movement, and make sputum easier to cough up. More |
23828-92-4 | 38 |
Appearance
This product is white loose mass or powder.
Indication
It is suitable for the expectorant treatment of acute and chronic respiratory diseases accompanied by abnormal sputum secretion and poor sputum removal function, such as acute exacerbation of chronic bronchitis, asthmatic bronchitis, bronchiectasis and bronchial asthma.
Usage and Dosage
15 mg 2 to 3 times a day
Adverse Reactions
This product is usually well tolerated. Mild gastrointestinal adverse reactions have been reported, mainly heartburn, indigestion, and occasional nausea and vomiting. Allergic reactions are rare, mainly rash. Severe acute allergic reactions have occurred in very rare cases, but their relevance to ambroxol hydrochloride is not certain. Such patients are usually allergic to other substances. See the instructions for details.
Precautions
Patients with known hypersensitivity to ambroxol hydrochloride or other ingredients of the formula are contraindicated.
Special Population Medication
Precautions for children: See the instructions for details Precautions for pregnancy and lactation: Preclinical trials and a large number of clinical trials used after 28 weeks of pregnancy have shown that there is no adverse effect on pregnancy. However, the drug should be used with caution during pregnancy, especially in the first three months of pregnancy. The drug can enter the breast milk, but the therapeutic dose should have no effect on the baby. Precautions for the elderly: No special precautions, please use according to the adult dosage.
Drug Interactions
The synergistic treatment of this product with antibiotics (amoxicillin, cefuroxime, erythromycin, doxycycline) can lead to increased concentrations of antibiotics in lung tissue. No clinically relevant adverse effects caused by co-administration with other drugs have been reported.
Storage
cool
Packaging Specification
30mg*10pcs/box
Manufacturer
Shandong YUXIN Pharmaceutical Co., Ltd.
-
Founded in:
2010-12-30 -
Address:
West side of the middle section of Luoqi Road, Luozhuang District, Linyi City -
Tax NO.:
91371300567713650P -
Registered Funds:
800 million yuan -
Email: